Epidemiology and Outcome of Anaphylactic Shocks Admitted to Intensive Care Unit: a French Retrospective Multicenter Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 339
- 试验地点
- 2
- 主要终点
- In-ICU mortality
研究概览
简要总结
Anaphylaxis is a severe life-threatening reaction following exposure to an antigen. Its incidence is progressively increasing in the general population over years, accompanied with an increased number of hospitalizations. Although rare, this condition is often associated with a significant morbidity and mortality. The mortality rate has been recently estimated at 0.84 (95% CI, 0.79 to 0.88) per million per year in the French adult population. Age, chronic medication and cardiac or pulmonary comorbidities have been reported to increase the risk of a severe reaction. Obesity, age and cardiovascular comorbidities have been identified as risk factors for fatal anaphylaxis. However, the risk factors for death after ICU admission have not been elucidated yet.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Being > 18 years old
- •suffered an anaphylactic reaction, regardless of the location or causative allergen
- •transferred alive in an ICU
排除标准
- •dead within less than one hour after admission
结局指标
主要结局
In-ICU mortality
时间窗: Day 30
The number of participants deceased within ICU hospitalisation
次要结局
- Amount of epinephrine(Day 30)
- Amount of norepinephrine(Day 30)
- Number and severity of organ failure(Day 30)
- Volume of fluid administered(Day 30)
- Extracorporeal life support requirement(Day 30)
